Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Equity

Artiva Biotherapeutics (ARTV) EBT Margin (2023 - 2024)

Historic EBT Margin for Artiva Biotherapeutics (ARTV) over the last 2 years, with Q1 2024 value amounting to 5514.74%.

  • Artiva Biotherapeutics' EBT Margin changed N/A to 5514.74% in Q1 2024 from the same period last year, while for Dec 2024 it was 24675.3%, marking a year-over-year change of. This contributed to the annual value of 26045.02% for FY2024, which is 259594800.0% down from last year.
  • As of Q1 2024, Artiva Biotherapeutics' EBT Margin stood at 5514.74%.
  • Over the past 5 years, Artiva Biotherapeutics' EBT Margin peaked at 42.13% during Q3 2023, and registered a low of 5514.74% during Q1 2024.